The key contributor to the growth of global ureteral stents include increasing number of urological procedures owing to sedentary life style and expanding elder population base. Poor dietary habits and fluid intake, increasing obesity levels and rising caseload of metabolic disorders may fuel the rate of market growth. Advancements in stents composition materials leading to minimise patient discomfort, mesh stent design and construction can give additional favour to the market. Availability of innovative smart phone applications has boost the growth of the market for stent case management and patient safety, which are useful for both physicians and patients. Complex procedure of stent placement, lack of skilled surgeons, complications after removal of the stent and discomfort in living with a ureteral stent with side effects such as increased frequency of passing urine and urgency to pass urine are the major restraints for ureteral stents market growth.
Global ureteral stents market is consolidated with a very few number of players. Boston Scientific, Bard Medical, Cook Medical, Coloplast are some of the key global players in the market. Boston Scientific acquired Endo international in 2015 representing its plans to grow. New players such as Allium Medical have established themselves very well in the market with their novel promising products. New players enter the market with some novelty in their products, which may be related to their composition material, user friendly communication interface platforms and better bio-compatibility.
Ureteral stents are medical devices made up of fine plastic tube. They are thin, flexible tubes which are used to restore urine flow through blocked ureters due to various disorders. These are placed in ureters through a surgical procedure commonly known as Ureteral stenting. One end of the device is placed in the urinary bladder while other end remains in kidney. The ends may be coiled to prevent dislocation of device. The stent is most often left in temporarily till the blockage is removed. Innovative interface platforms available in market for stent case management and patient safety has been useful for both physicians and patients. Epidemiological data reveals that the prevalence of stone disease is increasing which indicates that demand of ureter stents would increase in future.